File: /home/hnhtennm/mail/new/1759911423.M974425P12325.server1.quantilytics.org,S=22978,W=23585
Return-Path: <mail.izrpljeqxkyiudsu@email.techassetlibrary.com>
Delivered-To: hnhtennm@server1.quantilytics.org
Received: from server1.quantilytics.org
by server1.quantilytics.org with LMTP
id iP6GM/8d5mglMAAA0BcwpA
(envelope-from <mail.izrpljeqxkyiudsu@email.techassetlibrary.com>)
for <hnhtennm@server1.quantilytics.org>; Wed, 08 Oct 2025 08:17:03 +0000
Return-path: <mail.izrpljeqxkyiudsu@email.techassetlibrary.com>
Envelope-to: shabih.haider@hnhtechsolutions.com
Delivery-date: Wed, 08 Oct 2025 08:17:03 +0000
Received: from mta119-106.msgfocus.com ([185.187.119.106]:58175)
by server1.quantilytics.org with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <mail.izrpljeqxkyiudsu@email.techassetlibrary.com>)
id 1v6PM0-0004Eh-0h
for shabih.haider@hnhtechsolutions.com;
Wed, 08 Oct 2025 08:17:03 +0000
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; s=msgf; d=msgfocus.com;
h=Subject:List-Unsubscribe-Post:Message-ID:Reply-To:To:List-Unsubscribe:From:
Date:MIME-Version:Content-Type;
bh=tkOslO1MxS7M6iBEy8NwRV2A/er/Aovz3K8hESOhidk=;
b=O3wBMWDZUTF+20SsxvGIIUEyGCPkCEplIppqKMFT2orcNH5KIRfd2GacgxuQzYTyCBFvIBs8Z2Of
EWtLBpM6G1OZjo7YkLpF2b5QpXJiZS1IJ2TLxrf4oJ7385f01vMulP7wA39fDlaZSDC6avlBOSVI
IZEFfazBhYTpLZgsNos=
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=email.techassetlibrary.com; s=msgf;
t=1759910431; bh=tkOslO1MxS7M6iBEy8NwRV2A/er/Aovz3K8hESOhidk=;
h=Subject:List-Unsubscribe-Post:Message-ID:Reply-To:To:
List-Unsubscribe:From:Date:MIME-Version:Content-Type;
b=XRqSowGArEI4oJJD2howIF7gCRCScGJE4Nx+uTvZ/epmypI2NL0Z31uap2NjitioN
wpTbR+/20mB8VLTYb9Qs98s35Wu6P9uMahwjFPrjWKrLGoEJLuAMT/PcXwg79zbIuB
A30N1x18uaDiGCJqKTNiTO10x9gtlHTo1iWcF/MY=
Subject: Reminder: Digital content delivery for modern clinical trials
List-Unsubscribe-Post: List-Unsubscribe=One-Click
Message-ID: <wH1-83kD1Wj1b-RMR3-1nX17oG4yfDN0X@email.techassetlibrary.com>
Reply-To: Kate Lovell <kate.lovell@techassetlibrary.com>
To: shabih.haider@hnhtechsolutions.com
List-Unsubscribe:
<mailto:mail.izrpljeqxkyiudsu@email.techassetlibrary.com?subject=Unsubscribe>,<https://email.techassetlibrary.com/u/11WjlRaVqGkEpeb1f2pNb/list-unsubscribe>
From: Kate Lovell <kate.lovell@email.techassetlibrary.com>
Date: Wed, 8 Oct 2025 09:00:31 +0100
MIME-Version: 1.0
Content-Type: multipart/alternative; boundary="--1925D2D915D604C8022FAAA9"
X-Virtual-MTA: mta119-106
X-Spam-Status: No, score=0.7
X-Spam-Score: 7
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "server1.quantilytics.org",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: https://email.techassetlibrary.com/c/1zLpkRl8NRYd5KYgbCzdz9Ht
When patients join a clinical trial, access to clear, up-to-date information
about their investigational medication is critical. Traditional labels often
fall short, with limited space, small print, and language barriers.
Content analysis details: (0.7 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: msgfocus.com]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[185.187.119.106 listed in bl.score.senderscore.com]
0.8 BAYES_50 BODY: Bayes spam probability is 40 to 60%
[score: 0.5002]
0.0 RCVD_IN_VALIDITY_SAFE_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[185.187.119.106 listed in sa-trusted.bondedsender.org]
-0.0 SPF_HELO_PASS SPF: HELO matches SPF record
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
X-Spam-Flag: NO
----1925D2D915D604C8022FAAA9
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable
https://email.techassetlibrary.com/c/1zLpkRl8NRYd5KYgbCzdz9Ht
When patients join a clinical trial, access to clear, up-to-date informatio=
n about their investigational medication is critical.
Traditional labels often fall short, with limited space, small print, and l=
anguage barriers.
That=E2=80=99s why we created ePLY
https://email.techassetlibrary.com/c/1zLtkcGzxdtb4va7L0UWxLN4, a digital co=
ntent distribution platform that puts trial information in your patients=E2=
=80=99 hands=E2=80=94instantly.
Using QR codes and mobile-enabled hosting, ePLY delivers key content includ=
ing:
https://email.techassetlibrary.com/c/1zLBiTnqZUt71ZxQTNCouZYg
Label information
Patient instructions
Expiration dates
Marketing materials
Trial-specific updates
ePLY works with all our label types and supports any trial model. Plus, it'=
s fully customizable to meet your exact needs.
Watch Video
https://email.techassetlibrary.com/c/1zLFieIRJfY50JJItbY7tC3R
2025 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are =
the property of Thermo Fisher Scientific and its subsidiaries unless otherw=
ise specified. We hereby disclose that this email communication is for comm=
ercial purposes.
View the privacy policy
https://email.techassetlibrary.com/c/1zLJhA4isBt2ZtVA2AjQse9s.
Unsubscribe from receiving emails from Patheon pharma services.
Thermo Fisher Scientific
168 Third Avenue Waltham, MA 02451 United States
https://email.techassetlibrary.com/c/1zLNgVpJbWY0Ye7rBYFzqQf3
thermofisher.com
TechAssetLibrary is a KnowledgeCloud brand owned by ProspectBase UK Limited=
, company no: 15492457 whose registered office is: Wessex House, Teign Road=
, Newton Abbot, Devon, TQ12 4AA, UK.
You acknowledge that by accessing content via links or attachments your det=
ails may be passed to the content owner so they know who has received it, a=
nd may follow up with you by email, phone call or letter. To know more abou=
t how we process and protect your data, please see our privacy policy
https://email.techassetlibrary.com/c/1zLRggL9VisYWYjjbn1ipskE. The content =
of this email is intended for the person or entity to which it is addressed=
only. If you no longer wish to receive communications from us, please unsu=
bscribe https://email.techassetlibrary.com/u/11WjlRaVqGkEpeb1f2pNb using th=
e following link.
Kate Lovell
=20=20=20=20
Business Insight Executive
=20=20=20=20
TechAssetLibrary
=20=20=20=20
t: 0800 452 7766
e: kate.lovell@techassetlibrary.com
w: www.techassetlibrary.com
=20=20=20=20
TechAssetLibrary is a KnowledgeCloud brand owned by ProspectBase UK Limited=
, company no: 15492457 whose registered office is: Wessex House, Teign Road=
, Newton Abbot, Devon, TQ12 4AA, UK.
=20=20=20=20
You acknowledge that by accessing content via links or attachments your det=
ails may be passed to the content owner so they know who has received it, a=
nd may follow up with you by email, phone call or letter. To know more abou=
t how we process and protect your data, please see our privacy policy (http=
s://email.techassetlibrary.com/c/1zLVfC6AEDXWVIvaKLn1o4qf). The content of =
this email is intended for the person or entity to which it is addressed on=
ly. If you no longer wish to receive communications from us, please unsubsc=
ribe using the following link: https://email.techassetlibrary.com/u/11WjlRa=
VqGkEpeb1f2pNb.=
----1925D2D915D604C8022FAAA9
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable
<!DOCTYPE html>
<html lang=3D"">
<head>
<title></title>
<meta content=3D"summary_large_image" name=3D"twitter:card" />
<meta content=3D"website" property=3D"og:type" />
<meta content=3D"" property=3D"og:description" />
<meta content=3D"https://prospectbase.preview-beefree.space/7ZXs" property=
=3D"og:url" />
<meta content=3D"https://pro-bee-beepro-thumbnail.getbee.io/messages/11728=
12/1158613/2283207/13403810_large.jpg" property=3D"og:image" />
<meta content=3D"" property=3D"og:title" />
<meta content=3D"" name=3D"description" />
<meta content=3D"width=3Ddevice-width" name=3D"viewport" />
<style>
.bee-row,
.bee-row-content {
position: relative
}
.bee-button-content {
text-align: center
}
body {
background-color: #ffffff;
color: #000000;
font-family: Arial, Helvetica, sans-serif
}
.bee-row-3 .bee-col-2 .bee-block-1 a,
.bee-row-3 .bee-col-2 .bee-block-2 a,
.bee-row-3 .bee-col-2 .bee-block-3 a,
.bee-row-3 .bee-col-2 .bee-block-4 a,
.bee-row-3 .bee-col-2 .bee-block-5 a,
.bee-row-7 .bee-col-1 .bee-block-1 a,
a {
color: #7747FF
}
* {
box-sizing: border-box
}
body,
p {
margin: 0
}
.bee-row-content {
max-width: 645px;
margin: 0 auto;
display: flex
}
.bee-row-content .bee-col-w2 {
flex-basis: 16.6666666667%
}
.bee-row-content .bee-col-w5 {
flex-basis: 41.6666666667%
}
.bee-row-content .bee-col-w7 {
flex-basis: 58.3333333333%
}
.bee-row-content .bee-col-w10 {
flex-basis: 83.3333333333%
}
.bee-row-content .bee-col-w12 {
flex-basis: 100%
}
.bee-button a {
text-decoration: none
}
.bee-image {
overflow: auto
}
.bee-image .bee-center {
margin: 0 auto
}
.bee-row-1 .bee-col-1 .bee-block-1 {
width: 100%
}
.bee-image img {
display: block;
width: 100%
}
.bee-paragraph {
overflow-wrap: anywhere
}
@media (max-width:665px) {
.bee-row-content:not(.no_stack) {
display: block
}
}
.bee-row-1,
.bee-row-2,
.bee-row-3,
.bee-row-4,
.bee-row-5,
.bee-row-6,
.bee-row-7 {
background-color: #f1f1f1;
background-repeat: no-repeat
}
.bee-row-1 .bee-row-content,
.bee-row-2 .bee-row-content,
.bee-row-3 .bee-row-content,
.bee-row-4 .bee-row-content {
background-color: #ffffff;
background-repeat: no-repeat;
border-radius: 0;
color: #000000
}
.bee-row-1 .bee-col-1,
.bee-row-7 .bee-col-1 {
padding-bottom: 5px
}
.bee-row-2 .bee-col-1,
.bee-row-4 .bee-col-1 {
padding-bottom: 5px;
padding-right: 5px;
padding-top: 5px
}
.bee-row-2 .bee-col-1 .bee-block-1,
.bee-row-4 .bee-col-1 .bee-block-1 {
padding: 10px 20px 10px 25px
}
.bee-row-3 .bee-col-1,
.bee-row-3 .bee-col-2,
.bee-row-5 .bee-col-1,
.bee-row-6 .bee-col-1,
.bee-row-6 .bee-col-2 {
padding-bottom: 5px;
padding-top: 5px
}
.bee-row-3 .bee-col-1 .bee-block-1 {
padding-left: 15px;
padding-top: 15px;
width: 100%
}
.bee-row-3 .bee-col-2 .bee-block-1,
.bee-row-3 .bee-col-2 .bee-block-2,
.bee-row-3 .bee-col-2 .bee-block-3,
.bee-row-3 .bee-col-2 .bee-block-4 {
padding-bottom: 10px;
padding-right: 10px;
padding-top: 30px
}
.bee-row-3 .bee-col-2 .bee-block-5 {
padding-bottom: 10px;
padding-right: 10px;
padding-top: 25px
}
.bee-row-5 .bee-row-content {
background-color: #262262;
background-repeat: no-repeat;
border-radius: 0;
color: #000000
}
.bee-row-5 .bee-col-1 .bee-block-1 {
padding: 20px;
text-align: center
}
.bee-row-6 .bee-row-content,
.bee-row-7 .bee-row-content {
background-color: #555759;
background-repeat: no-repeat;
border-radius: 0;
color: #000000
}
.bee-row-6 .bee-col-1 .bee-block-1 {
padding-top: 30px;
width: 100%
}
.bee-row-6 .bee-col-2 .bee-block-1 {
padding-bottom: 25px;
padding-right: 20px;
padding-top: 25px
}
.bee-row-2 .bee-col-1 .bee-block-1,
.bee-row-4 .bee-col-1 .bee-block-1 {
color: #101112;
direction: ltr;
font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 17px;
font-weight: 400;
letter-spacing: 0;
line-height: 150%;
text-align: left
}
.bee-row-2 .bee-col-1 .bee-block-1 a,
.bee-row-4 .bee-col-1 .bee-block-1 a {
color: #43859e
}
.bee-row-2 .bee-col-1 .bee-block-1 p:not(:last-child),
.bee-row-4 .bee-col-1 .bee-block-1 p:not(:last-child),
.bee-row-6 .bee-col-2 .bee-block-1 p:not(:last-child),
.bee-row-7 .bee-col-1 .bee-block-1 p:not(:last-child) {
margin-bottom: 16px
}
.bee-row-3 .bee-col-2 .bee-block-1,
.bee-row-3 .bee-col-2 .bee-block-2,
.bee-row-3 .bee-col-2 .bee-block-3,
.bee-row-3 .bee-col-2 .bee-block-4,
.bee-row-3 .bee-col-2 .bee-block-5 {
color: #101112;
direction: ltr;
font-size: 19px;
font-weight: 400;
letter-spacing: 0;
line-height: 120%;
text-align: left
}
.bee-row-6 .bee-col-2 .bee-block-1,
.bee-row-7 .bee-col-1 .bee-block-1 {
color: #ffffff;
direction: ltr;
font-size: 12px;
font-weight: 400;
letter-spacing: 0;
line-height: 120%
}
.bee-row-3 .bee-col-2 .bee-block-1 p:not(:last-child),
.bee-row-3 .bee-col-2 .bee-block-2 p:not(:last-child),
.bee-row-3 .bee-col-2 .bee-block-3 p:not(:last-child),
.bee-row-3 .bee-col-2 .bee-block-4 p:not(:last-child),
.bee-row-3 .bee-col-2 .bee-block-5 p:not(:last-child) {
margin-bottom: 19px
}
.bee-row-5 .bee-col-1 .bee-block-1 a {
background-color: #e71316;
border-radius: 4px;
color: #ffffff;
direction: ltr;
font-family: inherit;
font-size: 16px;
font-weight: 400;
letter-spacing: 0;
line-height: 200%;
padding: 5px 25px;
width: auto
}
.bee-row-6 .bee-col-2 .bee-block-1 {
text-align: left
}
.bee-row-6 .bee-col-2 .bee-block-1 a {
color: #ffffff
}
.bee-row-7 .bee-col-1 .bee-block-1 {
padding: 15px 10px 10px;
text-align: justify
}
</style>
</head>
<body>
<div class=3D"bee-page-container">
<div class=3D"bee-row bee-row-1">
<div class=3D"bee-row-content">
<div class=3D"bee-col bee-col-1 bee-col-w12">
<div class=3D"bee-block bee-block-1 bee-image"><a href=3D"https://email.tec=
hassetlibrary.com/c/1zKLrpSPuoYxij3CtH3XN0Nv" target=3D"_blank"><img class=
=3D"bee-center bee-autowidth" style=3D"max-width: 645px;" title=3D"" src=3D=
"https://d15k2d11r6t6rl.cloudfront.net/pub/bfra/sjlpw73a/o9f/wdw/64z/Screen=
shot%202025-09-24%20182446.png" alt=3D""></a></div>
</div>
</div>
</div>
<div class=3D"bee-row bee-row-2">
<div class=3D"bee-row-content">
<div class=3D"bee-col bee-col-1 bee-col-w12">
<div class=3D"bee-block bee-block-1 bee-paragraph">
<p>When patients join a clinical trial, access to clear, up-to-date informa=
tion about their investigational medication is critical.<br><br>Traditional=
labels often fall short, with limited space, small print, and language bar=
riers.<br><br>That’s why we created <a style=3D"text-decoration: unde=
rline;" title=3D"https://www.patheon.com/us/en/our-capabilities/clinical-tr=
ial-services/clinical-trial-labeling.html?utm_campaign=3D&utm_source=3DEloq=
ua&utm_medium=3DEmail&utm_content=3DPI_EMN_MGSS-MSV_0925_THERMO-FISHER_EBLA=
ST-1OCT2025&utm_campaignID=3D&utm_campaign=3D2025-ctd&utm_campaignchild=3Dl=
aph&utm_specialty=3Depnpi&utm_campaignregion=3Dglb&utm_campaigncountry=3D&u=
tm_source=3Dcitl&utm_medium=3Dtpe&utm_content=3Deply-npi-citeline-bodybutto=
n-2025-10-01&utm_campaignassettype=3Dwpg&utm_term=3D&elqTrackId=3D1c7ff1024=
6b44125a751322f436be534&elq=3Dc3315c18aa234cb8802ac914e4c7485e&elqaid=3D117=
07&elqat=3D1&elqCampaignId=3D&elqak=3D8AF530CE6772AB57FFAFCF854A41BFEF094EF=
031EA708E69B4AB376CF0A7A4EB36F5#eply" rel=3D"noopener" href=3D"https://emai=
l.techassetlibrary.com/c/1zKTq6zGX5YtfNrlCtLpKeYH" target=3D"_blank">ePLY</=
a>, <b><i>a digital content distribution platform that puts trial informati=
on in your patients’ hands—instantly.</i></b><br><br>Using QR c=
odes and mobile-enabled hosting, ePLY delivers key content including:</p>
</div>
</div>
</div>
</div>
<div class=3D"bee-row bee-row-3">
<div class=3D"bee-row-content">
<div class=3D"bee-col bee-col-1 bee-col-w2">
<div class=3D"bee-block bee-block-1 bee-image"><a href=3D"https://email.tec=
hassetlibrary.com/c/1zKXprV7GrtrexDdbS78IR4i" target=3D"_blank"><img class=
=3D"bee-fixedwidth" style=3D"max-width: 70px;" title=3D"" src=3D"https://d1=
5k2d11r6t6rl.cloudfront.net/pub/bfra/sjlpw73a/5nj/7xx/1un/sda.png" alt=3D""=
></a></div>
</div>
<div class=3D"bee-col bee-col-2 bee-col-w10">
<div class=3D"bee-block bee-block-1 bee-paragraph">
<p>Label information</p>
</div>
<div class=3D"bee-block bee-block-2 bee-paragraph">
<p>Patient instructions</p>
</div>
<div class=3D"bee-block bee-block-3 bee-paragraph">
<p>Expiration dates</p>
</div>
<div class=3D"bee-block bee-block-4 bee-paragraph">
<p>Marketing materials</p><a href=3D"https://email.techassetlibrary.com/c/1=
5FTXlRc4rcTW5bQ53t5vEA9"><img src=3D"https://email.techassetlibrary.com/y/1=
1jiGq6rp6W8iQRV3CGaQq7v"></a>
</div>
<div class=3D"bee-block bee-block-5 bee-paragraph">
<p>Trial-specific updates</p><a href=3D"https://email.techassetlibrary.com/=
c/1cbBBoyeS2UsWlKRB9Wxi8Wj"><img src=3D"https://email.techassetlibrary.com/=
y/11jiGq6rp6W8iQRV3CGaQuLs"></a>
</div>
</div>
</div>
</div>
<div class=3D"bee-row bee-row-4">
<div class=3D"bee-row-content">
<div class=3D"bee-col bee-col-1 bee-col-w12">
<div class=3D"bee-block bee-block-1 bee-paragraph">
<p>ePLY works with all our label types and supports any trial model. Plus, =
it's fully customizable to meet your exact needs.</p>
</div>
</div>
</div>
</div>
<div class=3D"bee-row bee-row-5">
<div class=3D"bee-row-content">
<div class=3D"bee-col bee-col-1 bee-col-w12">
<div class=3D"bee-block bee-block-1 bee-button"><a class=3D"bee-button-cont=
ent" style=3D"font-size: 16px; display: inline-block;" href=3D"https://emai=
l.techassetlibrary.com/c/1zL1oNgypMYpdhP4LgsRHt9T" target=3D"_blank"><span =
style=3D"word-break: break-word; font-size: 16px; line-height: 200%; letter=
-spacing: normal;">Watch Video</span></a></div>
</div>
</div>
</div>
<div class=3D"bee-row bee-row-6">
<div class=3D"bee-row-content">
<div class=3D"bee-col bee-col-1 bee-col-w5">
<div class=3D"bee-block bee-block-1 bee-image"><img class=3D"bee-center bee=
-fixedwidth" style=3D"max-width: 188px;" title=3D"" src=3D"https://d15k2d11=
r6t6rl.cloudfront.net/pub/bfra/sjlpw73a/piy/v3s/vdk/Screenshot%202025-09-24=
%20183715.png" alt=3D""></div>
</div>
<div class=3D"bee-col bee-col-2 bee-col-w7">
<div class=3D"bee-block bee-block-1 bee-paragraph">
<p>2025 Thermo Fisher Scientific Inc. All rights reserved. All trademarks a=
re the property of Thermo Fisher Scientific and its subsidiaries unless oth=
erwise specified. We hereby disclose that this email communication is for c=
ommercial purposes.<br><br><a style=3D"text-decoration: underline;" rel=3D"=
noopener" href=3D"https://email.techassetlibrary.com/c/1zL5o8BZ98tnc20WkEOA=
G5fu" target=3D"_blank">View the privacy policy</a>.<br><br><a style=3D"tex=
t-decoration: underline;" rel=3D"noopener" href=3D"{{system.unsubscribeLink=
}}" target=3D"_blank">Unsubscribe</a> from receiving emails from Patheon ph=
arma services.<br><br>Thermo Fisher Scientific<br><a style=3D"text-decorati=
on: underline;" rel=3D"noopener" href=3D"https://email.techassetlibrary.com=
/c/1zL9ntXpStYlaMcNU3ajEHl5" target=3D"_blank">168 Third Avenue<br>Waltham,=
MA 02451<br>United States</a><br>thermofisher.com</p>
</div>
</div>
</div>
</div>
<div class=3D"bee-row bee-row-7">
<div class=3D"bee-row-content">
<div class=3D"bee-col bee-col-1 bee-col-w12">
<div class=3D"bee-block bee-block-1 bee-paragraph">
<p><font size=3D"1">TechAssetLibrary is a KnowledgeCloud brand owned by Pro=
spectBase UK Limited, company no: 15492457 whose registered office is: Wess=
ex House, Teign Road, Newton Abbot, Devon, TQ12 4AA, UK.</font></p>
<p><font size=3D"1">You acknowledge that by accessing content via links or =
attachments your details may be passed to the content owner so they know wh=
o has received it, and may follow up with you by email, phone call or lette=
r. To know more about how we process and protect your data, please see our =
<a style=3D"text-decoration: underline;" rel=3D"noopener noreferrer" href=
=3D"https://email.techassetlibrary.com/c/1zLdmPiQBPtj9woFtrw2DjqG" target=
=3D"_blank">privacy policy</a>. The content of this email is intended for t=
he person or entity to which it is addressed only. If you no longer wish to=
receive communications from us, please <a style=3D"text-decoration: underl=
ine;" rel=3D"noopener noreferrer" href=3D"https://email.techassetlibrary.co=
m/u/11WjlRaVqGkEpeb1f2pNb" target=3D"_blank">unsubscribe</a> using the foll=
owing link.</font></p>
</div>
</div>
</div>
</div>
</div>
<p style=3D"font-family: Calibri;">
Kate Lovell<br>
Business Insight Executive<br>
TechAssetLibrary
</p>
<p style=3D"font-family: Calibri;">
t: 0800 452 7766<br>
e: <a href=3D"mailto:kate.lovell@techassetlibrary.com
">kate.lovell@techassetlibrary.com
</a><br>
w: <a href=3D"https://email.techassetlibrary.com/c/1zLhmaEhlaYh8gAx2PRLBVwh=
" target=3D"_blank">www.techassetlibrary.com</a>
</p>
<p style=3D"font-family: Calibri; font-size: smaller;">
TechAssetLibrary is a KnowledgeCloud brand owned by ProspectBase UK Limited=
, company no: 15492457 whose registered office is: Wessex House, Teign Road=
, Newton Abbot, Devon, TQ12 4AA, UK.<br><br>
You acknowledge that by accessing content via links or attachments your det=
ails may be passed to the content owner so they know who has received it, a=
nd may follow up with you by email, phone call or letter. To know more abou=
t how we process and protect your data, please see our <a href=3D"https://e=
mail.techassetlibrary.com/c/1zLllvZI4wtf70MoCeduAxBS" target=3D"_blank">pri=
vacy policy</a>. The content of this email is intended for the person or en=
tity to which it is addressed only. If you no longer wish to receive commun=
ications from us, please <a href=3D"https://email.techassetlibrary.com/u/11=
WjlRaVqGkEpeb1f2pNb" target=3D"_blank">unsubscribe</a> using the following =
link.
</p><img src=3D"https://email.techassetlibrary.com/t/1nX17oG4yfDN0X.png" al=
t=3D"">
<!--[if lt mso 12]><img src=3D"https://email.techassetlibrary.com/r/1nX17oG=
4yfDN0X.png?c=3D1" alt=3D""><![endif]--><![if gt mso 11]><img src=3D"https:=
//email.techassetlibrary.com/r/1nX17oG4yfDN0X.png" alt=3D""><![endif]>
</body>
</html>=
----1925D2D915D604C8022FAAA9--